T0	Outcomes 153 212	objective response to chemotherapy using imaging modalities
T1	Outcomes 304 387	serum tumor markers (TMs), namely carcinoembryonic antigen, CA19-9, DUPAN-2, SPan-1
T2	Outcomes 455 502	Monitoring of serum TMs and computed tomography
T3	Outcomes 672 696	fluctuation rates of TMs
T4	Outcomes 872 897	time to progression (TTP)
T5	Outcomes 1158 1184	follows: fluctuation rates
T6	Outcomes 1350 1393	one-month earlier confirmation of treatment